Michael Schmertzler, Director at CYTOKINETICS INC (CYTK), bought 1,522,840 shares at $1.97 ($3.0M) on 2009-05-21, disclosed to the SEC on 2009-05-22.
Open-market purchase of $3.0M CYTK by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| PTCT | SELL | 2026-08-28 | $1.8M | — | Filing → |
| PTCT | SELL | 2026-08-21 | $1.8M | — | Filing → |
| PTCT | SELL | 2024-01-10 | $42K | — | Filing → |